[Species-specific antigenicity of xenogeneic bone treated with glutaraldehyde].
Present results showed that an extract of xenogeneic bone may inhibit the complement activity of some human sera, while an extract of xenogeneic bone treated with glutaraldehyde may show a lower inhibiting effect. This finding suggested that a preventive treatment in vitro with glutaraldehyde significantly decreases species-specific antigenicity of bone tissue.
D000447:Aldehydes / Q000276:immunology*; D000818:Animals; D000941:Antigens / Q000276:immunology*; D016025:Bone Transplantation; D001842:Bone and Bones / Q000187:drug effects* / Q000276:immunology; D003169:Complement Inactivator Proteins / Q000276:immunology; D005976:Glutaral / Q000276:immunology*; D006801:Humans; D066298:In Vitro Techniques; D051381:Rats; D013045:Species Specificity; D014020:Tissue Extracts / Q000276:immunology; D014183:Transplantation, Heterologous
D000447:Aldehydes; D000941:Antigens; D003169:Complement Inactivator Proteins; D014020:Tissue Extracts; D005976:Glutaral
Sull'antigenicità di specie dell'osso xenogenico trattato con glutaraldeide.